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Children’s heart disease in 
sub-Saharan Africa:  
Challenging the burden of disease
Africa’s population was estimated at 922 million in 2005, having 
doubled in 25 years, and quadrupled in 50 years;(5) it was expected 
to exceed one billion by the end of 2009. Children’s health issues 
are particularly prominent because of the large “youth bulge” in 
population distribution; more than half of Africa’s people are under 
25 years of age.(5) (Figure 1.)
The estimated under-5 mortality for sub-Saharan Africa is 148 per 
1 000 live births: that is 6 million children per year, 16 000 per day, 
one child every five seconds...(6) mostly due to communicable 
diseases. The needs of children with non-communicable diseases 
like heart disease are swamped; yet without appropriate treat- 
ment about one in three children born with congenital heart 
disease will die within the first month of life.(7) In the case of 
rheumatic heart disease one in five will die by the age of 15 years, 
and almost 4 in 5 will be dead by the age of 25.(8)
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INtrODUctION                                                                        
“Where you live should not determine whether you live.” – Bono
The vast majority of African children with heart disease have no 
access to treatment.
Once the “cradle of humankind” and home to major civilisations, 
Africa is a place of poverty with a burden of disease unlike any-
where else. The world’s 20 least developed nations are in sub-
Saharan Africa.(1) Although the role of developed nations in 
destabilising Africa bears much discussion, there are many other 
factors, including poor governance, corruption, a lack of democracy 
and civil unrest, while political priorities seldom include health-
care.(2) International aid continues to pour in to the continent, but 
is offset by crippling foreign debt, which costs countries more than 
the aid received, and four to six times more than is spent on 
healthcare.(2,3) 
It is in this complicated context that many of us would seek 
foster care for children with heart disease, a largely hidden non-
communicable disease that is understandably both understudied 
and for the most part ignored.(4)
children with heart disease in Africa have little or no access 
to treatment of any kind, and cardiac surgical services are 
virtually absent outside a handful of centres in a few of the 
wealthier nations. there is little reliable data concerning 
the prevalence of congenital or acquired heart disease in 
African children, but there is sufficient information to 
indicate that the burden of cardiac disease is vast. this major 
non-communicable disease is largely hidden, overshadowed 
by the incidence of communicable diseases. there is as yet 
little evidence of the hoped-for epidemiological transition 
toward non-communicable diseases amongst children in 
Africa. the burden of congenital heart disease is only part of 
the problem, with rheumatic heart disease (rHD) remaining 
the commonest cardiac problem, related to poor socio-
economic conditions. rHD is the most preventable form of 
cardiac disease, yet there is little preventive work being 
done. the many obstacles to developing paediatric cardiac 
care are discussed, and some possible ways forward are 




















“Cardiac Surgery is the first request from a lot of poor countries.” 
– Daniel Sidi, Nov.3rd 2008, SAHA meeting.
bUrDEN OF DIsEAsE                                                               
The “big three” communicable diseases – malaria, HIV and tuber-
culosis – dominate, and the “epidemiological transition” toward 
non-communicable disease that is reportedly beginning in the 
adult population(9) is not yet seen for children. Reasons for this 
relate to persistent poverty and malnutrition, lack of basic sanita-
tion and clean water, and poor access to healthcare.(10) Cardiac 
diseases simply add to this enormous health burden for the average 
child. 
Acquired heart disease 
Acquired heart disease in Africa is predominantly rheumatic heart 
disease (RHD), consequent upon recurrent attacks of acute rheu-
matic fever (ARF). A single attack of ARF may progress to RHD, 
but most RHD results from the cumulative damage of repeated 
attacks.(11,12,13,14)
Over the past century the incidence of ARF and RHD has declined 
steeply in developed countries; the initial and most rapid decline 
was before the antibiotic era, due mainly to improving socio-
economic conditions.(15,16,17) RHD is today rarely seen in developed 
nations;(18,19,20) already by the 1980s it was thought to be virtually 
eradicated.(20) Yet RHD remains the most common form of cardiac 
disease in children and young adults in Africa and a major public 
health concern.(16) It is the most preventable form of cardiac 
disease, though difficult to treat effectively without surgery,(13) 
which is expensive, generally unavailable, and involves high-cost 
prostheses;(20) it is also only a partial solution, especially in a 
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FIGUrE 1:  Age pyramid: south Africa
the South African age pyramid illustrates the classic prominent “youth bulge” of developing nations. the bulk of the population is under 25 years old, 
the age group most affected by the twin epidemics of acquired (rheumatic) and congenital heart disease.
Deaths from RHD focussed in 10-25 age group
Source: United Nations World Population Prospects: 2008 Revision
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resource-poor setting where adequate coagulation control is 
unlikely.(21,22,23)
While there is no reliable data on the incidence of ARF in Africa, (24) 
the reported incidence of RHD varies widely. In developed coun-
tries it is less than 0.5 per 1 000 population,(25) but is high in poor 
nations, for example 78 per 1 000 in Samoa.(26) In Africa, early 
reports based on auscultatory screening of school-going children 
gave incidences from 2.7 to 20 per 1 000 population.(16,27,28,29) 
Recently Marijon et al reported an incidence in Mozambique of 
30.4 per 1 000 using echo-based screening of schoolchildren,(30) 
probably a better estimate. Because of the difficulty in obtaining 
data, it is possible that the true incidence in many areas is even 
higher. Using echocardiography, Bonhoeffer reported an incidence 
of mitral regurgitation in rural Kenya of 62 per 1 000.(31)
One third to half of all cardiac hospital admissions in developing 
countries are due to RHD, with an average length of stay of 3 to 4 
weeks.(32,33) The typical age affected is 5 to 18 years.(32,33,34) There is 
widespread evidence that in developing nations RHD occurs at a 
younger age than in developed countries, and also progresses 
more rapidly, though this may reflect more frequent attacks of 
ARF,(33,35,36,37,38,39,40,41) as without intervention, the sequence of 
events is predictable: after the initial infection with Lancefield 
group A β-haemolytic streptococci 3% of patients develop ARF 
approximately 19 days later.(42) At reinfection, the incidence in-
creases sharply to more than 75% of patients.(43,44,45) 
During ARF, carditis is present in 40-80% of patients; of those 
with carditis, 90% will develop chronic progressive RHD.(46,47,48,49) 
(Figure 2.) 
The initial carditis is characterised by fibrinoid collagen degenera-
tion followed by a proliferative phase 1-6 months later. At that 
stage, the pathology is defined by annular dilatation, chordal elong-
ation and anterior leaflet prolapse.(50)
Thus the hallmark of acute rheumatic carditis is the pan-systolic 
murmur of mitral regurgitation (MR). If heart failure occurs in the 
wake of acute carditis with MR leading to LV dilatation, only sur- 
gical correction can lead to improvement.(50) The severity of LV 
dysfunction correlates more with the extent of the valvulitis than 
with the myocardial injury, although myocarditis co-exists in 30% 
to 70% of cases.(51) Eighty to 90% of those with severe MR during 
an ARF attack will develop clinically significant RHD. Of 9-year old 
children surviving ARF, 20% will be dead by the age of 15 years(52) 
and more than 70% by 25 years.(53,8) The majority of the latter 
group will have mitral and aortic regurgitation at death. Due to 
ChildrEn’S hEArt diSEASE 
FIGUrE 2:  An outline of the process from streptococcal infection to rheumatic heart disease. Millions are quietly dying from rhd in Africa, with 
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the chronic valvulitis, survivors typically develop mitral stenosis on 
top of MR,(53,54) its incidence increasing with age.(37)
The economic effects of RHD on communities are well de-
scribed.(53,55,56) Without access to surgery, the costs of repeated 
hospitalisation are significant. There are also intangible costs from 
premature disability and death, endocarditis and stroke, and loss of 
schooling and training.(25,35,55,57,58,59,60,61) Two-thirds of children with 
RHD leave school early.(62) RHD indirectly affects national pro-
ductivity, the young adults it affects being the most productive 
segment of the population.(60,62,63) RHD is also responsible for 10% 
of maternal deaths,(64,65) and is the main predisposing factor for 
infective endocarditis in Africa,(66,67,68,69) occurring at a mean age of 
27 years.(70)
Congenital heart disease 
Incidences of “significant” congenital heart disease (CHD) (i.e. 
what will require expert cardiological care at some stage) are 
generally reported at about 1% of live births or slightly less,(4,71,72,73) 
with eight common types of lesions making up 85% of all clinically 
significant CHD (ventricular septal defect, atrial septal defect, 
patent ductus arteriosus, pulmonic stenosis, tetralogy of Fallot, 
coarctation of the aorta, aortic stenosis, atrioventricular septal 
defect.)(72)
Most reliable studies indicate that, with only minor variations, the 
incidence is constant worldwide, across geographic and ethnic 
backgrounds, and in spite of variations in socio-economic 
conditions.(4,72,74) Thus it is valid to extrapolate these estimates to 
developing nations.
There are factors that may in fact suggest a higher estimate. For 
example, CHD may be undetected in infancy, not being included 
in studies that tend to focus on infancy;(74) one in four cases of 
CHD in the UK is diagnosed later in childhood.(75) In the USA at 
least 10% of patients with CHD first present in adulthood.(76)
Without appropriate treatment, about half of those born with 
significant CHD will die in infancy or early childhood, a third of 
them within the first month of life.(77) Most who survive longer will 
become debilitated by the cardiac defect.(7,77) Thus, of the 
approximately 50 million live babies born every year in Africa,(5,6) 
as many as 500 000 will have significant CHD that will require 
expert cardiological care; about half will die within a few years of 
birth. There is also a large pool of older children and adults with 
CHD that survived the early years who are debilitated by the 
disease. This is while paediatric cardiac medicine has advanced to 
the point that outcomes for children with heart lesions is in most 
cases excellent. 
The exact cause of CHD is not known in most cases, though there 
are known contributory factors. These include genetic defects and 
chromosomal abnormalities, maternal intrauterine viral infections 
such as rubella, certain medications taken in early pregnancy, 
consanguineous marriages, etc.(78)
PrEVENtION                                                                      
Nowhere is the absurdity of a lack of prevention of RHD, in the 
face of heroic efforts to treat it, better described than in McLaren’s 
1994 statement likening it to “attempting to mop up the water on 
the floor while leaving the faucet open.”(79) On purely economic 
grounds, it is clear that prevention of RHD is an urgent need.(8,33) 
ARF can be prevented through timely antibiotic treatment for 
streptococcal sore throat (primary prophylaxis); progression to 
RHD through recurrent attacks can be prevented by ongoing 
antibiotic therapy (secondary prophylaxis).(80) Secondary prophyl-
axis appears to be a most cost-effective strategy for Africa.(33,80) 
It may be unrealistic to expect to see advanced paediatric cardiac 
care in the near future in poor countries, but it is possible that 
prevention of ARF/RHD could be incorporated into most basic 
health systems, as the Indian example shows.(81) 
A welcome development in this regard was the adoption, at the 
first All Africa Workshop on Rheumatic Fever and Rheumatic 
Heart Disease in 2005, of the “Awareness, Surveillance, Advocacy, 
Prevention” (A.S.A.P.) proposal, aimed at mounting an effective 
prevention strategy in Africa under the auspices of the Pan African 
Society of Cardiology (PASCAR).(82)
trEAtMENt                                                                       
history
Paediatric cardiac surgery in Africa was inaugurated in March 1958 
when Christiaan Barnard closed an ASD in an 8 year-old child at 
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the Red Cross War Memorial Children’s Hospital in Cape Town. 
Over the ensuing decade children’s heart surgery centres sprang 
up in most of the major centres in South Africa, and also a few in 
Africa, including in Egypt and Uganda. However, while this phase 
of rapid growth proceeded briskly in the developed world, it 
faltered in Africa for many reasons. Some first-class medical facili-
ties were lost through skilled personnel leaving for greener past-
ures, some like the Makerere University unit in Uganda were 
closed in the midst of political strife, and many simply could not 
afford the ongoing expense. After the Declaration of Alma-Ata 
was adopted at the International Conference on Primary Health 
Care in Kazhakstan in 1978,(83) government policies shifted further 
away from tertiary health care funding.
In the early 1970s the well-known period of fly-in missions began, 
with expert visiting teams operating on a small number of care- 
fully selected patients. At about the same time many non-govern-
mental organisations (NGOs) began funding the transfer of selected 
indigent patients to first-world units with spare capacity. These 
attempts to help have been criticised in many ways, primarily for 
being the proverbial “drop in the ocean” at great expense, though 
undoubtedly many lives have been saved. It is clear though that 
unless local healthcare expertise is built up through the process, 
these exercises are at best not cost-effective, and at worst a waste 
of donor money that could have been used for something more 
sustainable.(23,84,85) 
NGOs have generally now shifted focus towards building long- 
term partnerships with recipient sites with a vision to eventually 
develop autonomous local services. There is a growing consensus 
about the need to work together to build regional centres which 
themselves can become a resource to surrounding areas and 
countries through satellite outreaches.(84,85,86,87) Such regional “sur-
gical hubs” could form training and resource bases for surrounding 
countries, with international aid coordinated at one centre rather 
than being diluted through multiple small efforts.
NGO-sponsored partnerships (e.g. “Save a child’s heart”) are 
pioneering another approach: a cardiologist, or a physician with a 
cardiology interest and an echo machine, establishes a clinic with 
diagnostic and post operative follow-up abilities, and basic labora-
tory facilities. Over a training period of three to 15 months a local 
team is established, with assistance to procure equipment, and 
basic surgery gradually begins, complex cases being flown to 
mentor institutions.
Surgery
One of the dilemmas of RHD in Africa is that it may manifest in 
children or in adulthood, when those who survive multiple attacks 
of ARF develop progression of their valve lesions. At this point 
typically only surgery will help, highlighting the need for both adult 
and paediatric cardiac surgical services. Paediatric services typically 
develop on the back of workable adult services, but there are far 
too few adult services in Africa. Similarly, facilities to monitor anti-
coagulation after valve replacement are virtually non-existent.(88)
In spite of years of effort, there is still little cardiac surgery happen-
ing in Africa. For example, Nigeria hosted their first fly-in mission 
35 years ago, in 1974. Over the subsequent three decades only 102 
patients underwent cardiac surgery, about half of them children, 
some by visiting teams and some by local surgeons.(89) There are 
believed to be about 15 trained cardiac surgeons in the country, 
and yet no active service is available due to lack of infrastructure. 
Kenya, on the other hand, having begun about the same time, has 
managed to build a cardiac service spread across four hospitals, 
including both state-funded and private facilities, and including a 
basic paediatric service.(90)
Most of Africa relies on flying paying patients, or donor-funded 
patients, to centres off the continent, or hosting short-term visits of 
skilled personnel. There is a marked lack of coordination in the 
latter and some NGOs have not learnt the lessons of sustainability. 
For example, there has been a surgical team visiting Zambia from 
Uzbekistan once per year for 14 years, in which time 76 adult 
patients have had cardiac surgery, but there has been no local 
infrastructure development.(91)
A warning may well be sounded about the South African situation, 
where the number of children operated on in the state services 
has decreased significantly over the past decade, and the services 
are seriously under-serving the population.(92)
Currently about 2 500 to 3 000 African children get operated on 
annually for all forms of heart disease, most of them in South Africa 




















and a small number of other centres.(93) A large proportion of 
these are patients with money or medical insurance to support 
private care. A further small number has surgery at great expense 
to donor organisations through fly-in expert teams, or being 
taken to centres in developed nations. There is a growing willing-
ness in Africa and internationally to work together to improve this 
situation, but no clear strategy is in place.
New catheter-based technologies, the area of fastest growth in 
cardiac care these past 10 years, do have potential for Africa. 
Dr. Philip Bonhoeffer introduced balloon valvuloplasty in Kenya in 
the early nineties, and has taught local cardiologists how to do the 
procedures.(94) Such interventions can reduce costs and improve 
access to cardiac therapies, though typically costs remain pro-
hibitive.
A further cost-effective alternative to surgery for RHD could be 
durable valves which need no anticoagulation, implanted through 
a relatively straightforward catheter-based approach in secondary-
level hospitals. The seeds of this possibility do exist, although 
exorbitant costs are still an issue. Unhappily most research funding 
is directed toward first-world needs for both pharmaceuticals and 
technology.(95) 
Other approaches that were commonplace in the early days of 
cardiac surgery could be appropriate for developing nations unable 
to afford high tech developments. For example, closed mitral valvo-
tomy using a Logan-Tubbs dilator, which cheaply and effectively 
saved thousands of lives from 1954 into the 1980s before expen-
sive catheter-based alternatives came into vogue.(96,97,98) Many 
cardiac centres still have the old dilators, though the skills required 
for the procedure are almost lost. 
ObstAcLEs                                                                        
If the communicable disease burden amongst children in sub-
Saharan Africa should diminish, cardiac diseases will be highlighted 
as the major non-communicable problem.(10) However, more 
important than individual diseases are the “prior questions,” the 
issues that drive the problem. If these questions were resolved, 
the burden of disease would shift toward non-communicable 
disease, the so-called “epidemiological transition” that is hoped 
for.(9) The “prior questions” that block the shift include: socio-
economic issues of malnutrition and poverty, complicated by 
recurrent drought and famine; the increasing economic divide and 
the economic policies of wealthy nations, with globalisation and 
marginalisation; poor health infrastructure, referral systems, trans-
port infrastructures; political priorities focused on issues other 
than health; civil unrest and war ; the “brain drain”, a virtual evacu-
ation of skills; and the debilitating effects of foreign aid and foreign 
debt.
In many countries more money is spent on servicing debt than on 
health and education combined.(2,99) On average 15% of the GDP 
of African states is in the form of foreign aid, yet the cost of ser-
vicing foreign debt is far more than aid received; economist 
Andrew Mwenda says foreign aid that is mostly in the form of 
budget support makes “government employment the best busi-
ness opportunity”, and stifles economic growth;(100) “Our govern- 
ments seek profit through outside aid not through their own 
people.” He appeals to the West to stop financial aid and rather 
help to empower individuals. Aid has indeed been rapidly reducing 
with the worldwide financial crisis, while the debt crisis worsens.
Partly to address these background issues, the “Millennium Devel-
opment Goals” (MDGs) were agreed upon at the United Nations 
Millennium Summit in 2000, incorporating leaders from 191 nations, 
aiming to meet them by 2015.(101) Addressing children’s heart 
disease is part of the context of goal number 4, to “reduce by 
two thirds the mortality rate among children under five.” It is 
most unlikely that this will be achieved by 2015,(102,103) but any 
progress made will make paediatric heart disease increasingly 
important as a cause of morbidity and mortality. Progress would 
also free up health resources.
Alarmingly, the under-5 mortality in South Africa has actually 
increased,(104) even though there has been a small decrease in 
Africa as a whole over the first 8 years of the MDG process.(104)
This context of extreme poverty and unmanageable burden of 
disease must be part of our consideration in seeking to develop 
cardiac care. However, if we can benefit children with cardiac 
disease using funds that would not otherwise be made available 
for the broader problems, then the overall healthcare infrastruc-
ture would surely benefit.
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sOME sUGGEstED WAYs FOrWArD                              
The task seems overwhelming, yet many organisations and indivi-
duals have taken up the challenge, and some progress has been 
made, albeit slow. Major reasons for slow progress are lack of 
funding and lack of cooperation (or lack of interest?) at local 
government levels to enable sustainability of a cardiac programme. 
Health expenditure is a large part of the GDP in developed 
nations, but only a small fraction in African countries,(84,105) keeping 
most tertiary services out of reach. Many strategies have been 
tried to improve the situation, but the main question is: How can 
we accelerate progress? Here are some suggestions. 
Work together
Those of us currently involved in paediatric cardiac care in Africa 
need to work together, coordinating our efforts to become as 
cost-efficient and appropriate as possible, seeking to be a pressure 
group that can attract attention and action from local govern- 
ments as well as international groups. Efforts to help, especially 
from the developed world, need better coordination in partner-
ship with Africans so as to avoid duplication of efforts and waste 
of resources. PASCAR is a potential forum for developing such 
cooperation, and discussions along these lines were begun at the 
PASCAR meeting in Nairobi in 2007. There are also many models 
of different approaches being tried that could become part of a 
larger coordinated effort to provide services for Africa, for example:
Children’s Heartlink is a USA-based NGO which has moved 
its focus from sending expensive missions to building local 
expertise. They are currently working in various centres in 
Africa, including at our unit in Cape Town, to support, train 
and develop local personnel in cost-effective ways. These 
include training/teaching missions of experts from first-world 
units, and twinning arrangements of African units with over- 
seas units, with short-term staff exchanges. They have helped 
our unit to twin with Stanford University in California, and 
short-term staff exchanges have started.
The Walter Sisulu Paediatric Cardiac Centre for Africa is an 
example of an NGO raising funds to utilise excess capacity in a 
private unit to facilitate surgery for indigent patients who 
otherwise would have no access to care.
■
■
The Namibia Heart Project was initiated in 2007 following an 
intergovernmental agreement between Namibia and South 
Africa whereby the two governments would share the cost of 
developing a new cardiac service in Windhoek through a 
partnership with the University of Cape Town. Negotiations 
with other African governments are also ongoing.
The Italian NGO Associazione Bambini Cardiopatici nel Mondo 
is currently building their third paediatric cardiac centre in 
Africa. They are working toward training local expertise in 
these centres in partnership with the UK-based Chain of 
Hope NGO.
We have partnered with the French NGO La Chaine de 
L’Espoir in surgical missions to Mozambique, in the under-
standing that it is more efficient and cost-effective to use 
teams from a neighbouring country.
Interaction and mutual support could become a continent-wide 
network to share ideas and frustrations and help build a community 
that will promote, build, and sustain cardiac care. (see Figure 3.) 
Build local infrastructure through teams
There is no point in training a surgeon who has no local infrastruc-
ture in which to work, yet this has been done many times, usually 
because the individual seeks out the training for him- or herself. 
There are in Africa trained cardiologists with no surgical support, 
and vice versa. A full support team is required for a cardiac 
service.(73) We know of a group who could not operate for lack of 
a perfusionist, so we trained one of the surgeons in perfusion 
technology, a relatively quick process. Equipment is vital too. We 
are trying to source a bypass pump for another group who can- 
not operate for lack of one.
The goal of training must be a complete local team that can 
sustain a programme. This requires coordination; training centres 
must liaise with administrations, preferably university centres 
where peer pressure and academic values will form strategies, and 
not with individuals. Training need not all be in one centre or 
even in one country, as long as the team strategy is in place.
Support from a local authority or university has proven important 
























a local service.(87) A degree of education of the local community 
and recruitment of political leadership is important.
Paid fellowships in South Africa for Africans could help us if we 
are, as some say, training too many surgeons. Funding is commonly 
an issue for Africans seeking training. 
An example of coordinated training is the Namibian Heart Project: 
we are training personnel in our unit at all levels, aimed at forming 
an autonomous team in Windhoek, whilst some key persons of 
the team are training at other units. A coordinated approach en-
sures there are no gaps to prevent the service being initiated 
and sustained.
Training partnerships with large units in developed countries are of 
benefit to both sides; visiting first-world personnel are exposed 
to pathology they seldom see. 
Prevention
As has been mentioned, secondary prophylaxis of rheumatic fever 
is an important strategy for RHD.(8,24,33,106) Many notable successes 
have been reported through prevention programmes with de-
creased prevalence, hospital morbidity and mortality; for example 
in Cuba, Costa Rica, Egypt, Martinique and Guadeloupe,(12,16,60,61,107, 
108,109,110,111,112,113) and the development of the A.S.A.P. proposal 
holds similar promise in this regard for Africa.(82) Having said this, 
support and motivation for prevention would be strengthened in 
the context of a curative (surgical) programme, and the latter 
needs to be promoted for the sake of the millions who already 
have crippling RHD in Africa.
“You cannot have an effective prevention programme if you 
don’t treat those affected by the disease today.” – Daniel Sidi, 
Nov.3rd 2008, SAHA meeting.
Simplify detection, diagnosis and treatment
If we move away from the first-world approach of sophisticated 
technology helping with detailed anatomical diagnoses, it could 
open the door to more ready detection and diagnosis of basic 
cardiac lesions.(74) With the growing network of secondary or 
regional hospitals in Africa, there is place for echocardiography 
technologists using low-end cheaper machines to screen for 
common cardiac lesions, with the possibility of selective referral 
to regional centres for surgery. (Figure 4) In Nigeria, for example, 
the six state teaching hospitals that have hosted brief episodes of 
cardiac surgery through visiting teams are amongst 68 state and 
private general training hospitals, with an additional general referral 
hospital in every major city. Such vast infrastructures hold promise; 
FIGUrE 3:  the population density of Africa suggests the positioning of regional surgical referral centres, and there are a few basic cardiac surgical 
services available. For many healthcare systems in Africa, Cardiac surgery is their first request.
Population densities in Africa suggest where regional 
surgical centres are most needed.
Source: United Nations Environment Programme. Global Resource 
Information Database. African Population Database Documentation.
Yellow dots indicate functional cardiac surgical units 
outside of South Africa, some of which operate on  
some children.
African countries that have consulted with the UCT 
cardiothoracic unit seeking collaboration on  
paediatric cardiac services within the past year.
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there is perhaps a place to begin with a simplified approach to 
surgical programmes, perhaps emulating the early years of cardiac 
surgery in the 1950s. Mobile diagnostic teams at the township level 
are already an emerging reality in South Africa. Mobile clinics with 
traveling technologists along the model of the “Save a child’s heart” 
programme could channel children requiring specialist attention to 
referral centres, where today’s transapical catheter technologies if 
radically simplified could be applied by trained local teams without 
surgical backup. The risk of no backup would be far outweighed by 
the lives saved. 
Daniel Sidi, speaking at the 9th Annual Conference of the SA 
Heart Association last year, said of the multiple new secondary 
level hospitals: “They fear to practice any cardiac surgery while 
they already perform visceral and orthopaedic surgery.” 
data and technology 
The global expansion of cheap and improved communications 
technology, and the rapidly spreading access to internet even in 
remote areas holds much potential for training and sharing of 
ideas and advice. In many parts of Africa internet access is easier 
than telephone communications. In 2001 James Cox of the World 
Heart Foundation proposed the use of internet technology to 
share knowledge and promote education through live internet 
conferences, expert email consultations, and even making major 
journals available free of charge.(86)
Some of his goals are coming to fruition. Some journals are offering 
free online access to back-issues. The first live teleconference of 
the World Heart Foundation was held late in 2008, focused on 
Vietnam and Asia, but open to all.(114) Sophisticated telecon- 
ferencing equipment is being investigated by the South African 
Department of Health for installation at major centres around 
the country with a vision of building a national network. This 
could be spread to neighbouring countries at little extra cost. 
PASCAR could again be a useful facilitator.
Coordination of personnel data on a database of trained experts 




There is a great deal of inappropriate and even unethical research 
going on in Africa, much of it driven by the needs of the developed 
world. There are university medical complexes without basic 
laboratory facilities who have an MRI scanner, because a foreign 
foundation needed it for a particular project. The medical com-
munity of Africa needs to take a stand on appropriateness of 
research and expenditure.
Simple documentation of epidemiology would be an suitable start 
as a route to pressuring funders. There is, for example, no good 
data on the incidence of acute rheumatic fever in Africa, and at 
one time it was thought not to be a significant problem.(24)
Plugging the “brain drain”
The lack of appropriate remuneration is commonly considered the 
main reason for loss of skills from Africa, but there are many other 
important causes; lack of team support to enable cardiac surgery, 
lack of equipment, political uncertainty, poor career prospects, and 
pressure from the disease burden are some of them.(2,4) Active 
recruitment by developed nations also contributes; the best train-
ees from Africa are lured away. South Africa, even our own institu-
tion, is part of this problem.
An example of the scope of the dilemma: the Malawi Medical 
School in Blantyre has funded 21 doctors for specialist paediatric 
training in developed nations over 10 years; 18 completed the 
training, but only one has returned to Malawi, in spite of various 
incentive programs.(116)

























FIGUrE 4: the rapid increase in number of secondary level 
hospitals in sub-Saharan Africa.
Source: World Health Organisation. Regional Office for Africa. The health of the people: 
the African regional health report. 2006. http://www.afro.who.int/regionaldirector/african_
regional_health_report2006.pdf




















Support groups need to address this. Institutions and governments 
need to be taken to task for the way they use personnel from 
developing nations to make up their own shortfalls.
 
recommendations for international organisations
Apart from all the above discussion, international aid groups should 
also be encouraged to:
Coordinate efforts between organisations and with local 
African efforts.
Undertake advocacy for increased international assistance 
through government policies.
Engage African governments on issues of health policy.
Learn from one another ; some NGOs have gone through a 
long learning curve and have much to teach on how to help 
Africa.
cONcLUsION                                                                          
“Every observer of human misery among the poor reports that disease 
plays the leading role.” – Irving Fisher (116)
There is a hidden epidemic of dying and disabled children in Africa. 
There is much that the world’s cardiac practitioners could do to 
address the problem, and there seems to be a growing willingness 
in the cardiac community to do just that, but little coordination or 
agreement about strategy. It will take a lot of time and effort, and 
no small amount of sacrifice, to make any significant change. 
As cardiac practitioners in Africa, we need to take a lead in directing 
and advising, in open collaboration with one another and with our 
colleagues throughout the continent and internationally. Children 
have a particularly raw deal with heart disease; the major ordeal of 
surgery has to be endured before they can even begin on the 
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